$HIMS stands out as one of my highest-conviction picks for 2026. Once they have that proof, $HIMS stock will grow rapidly.

Summary: Highest-conviction long HIMS into 2026 on GLP-1 tailwinds, international expansion, and new treatments; NVO/LLY benefit from current GLP-1 patent exclusivity until 2027.

structural marker; pre-classified as canonical yfinance ticker

Drug Manufacturers - Specialty & Generic

$HIMS stands out as one of my highest-conviction picks for 2026. However, the stock is currently facing three distinct headwinds. Below, I outline these challenges and explain why I expect the narrative to shift significantly.

The pharma industry is undervalued right now: Investment moves in waves, and AI is the hot topic right now. Every company has to mention AI in their quarterly reports to stay relevant. As investors and institutions do not want to miss this wave, they have moved a lot of money towards the AI sector. A direct result is that other industries are overlooked at the moment, and the pharma industry is one of them. I believe that capital allocation will be much more balanced in 2026.

GLP-1 regulations: People still see GLP-1 as an obesity drug. Investors still underestimate the power of GLP-1. Studies show that GLP-1 significantly helps with cardiovascular health, kidney diseases, addiction, neurological conditions, sleep apnea, fatty liver, fertility, chronic inflammation, and more. The only reason we don’t all take a daily GLP-1 pill is because of the patents held by $NVO and $LLY. At this moment, they are the only two companies allowed to legally produce GLP-1 products, but the first patents will expire in 2027. Once those patents expire, a lot of cheaper GLP-1 alternatives will hit the market. I believe that governments will start sharing the wide variety of benefits that GLP-1 provides, and the market will boom. The $HIMS platform is ideally positioned to benefit from this pivot.

Negative sentiment: $HIMS has been releasing a lot of positive news lately, although the market is not reacting to it. They announced major international expansion and now have access to Canada, France, the UK, and Germany. They rolled out new personalized treatments for menopause and low testosterone, and they are launching a diagnostic arm offering lab testing. Without all those new announcements, $HIMS traded at $70; with these new features, it trades at $35. Investors are waiting for proof that these new initiatives will feed platform growth. Once they have that proof, $HIMS stock will grow rapidly.


The only reason we don't all take a daily GLP-1 pill is because of the patents held by $NVO and $LLY. At this moment, they are the only two companies allowed to legally produce GLP-1 products


the patents held by $NVO and $LLY. At this moment, they are the only two companies allowed to legally produce GLP-1 products


Summary: Highest-conviction long PL with 300% upside to $67.3 price target; SaaS-like recurring revenue, data moat, and government contract expansion underpin thesis.

$PL remains my highest-conviction play in the space economy. Based on current fundamentals and their expanding contract pipeline, I see a clear path to a 300% upside from these levels.

Price target: $23.91 -> $67.3

Most investors look at Planet Labs and see satellites. They see capital expenditure. They see launch risks.

They are missing the forest for the trees.

Planet Labs is not a normal space company. Planet Labs is a SaaS Database company with cameras in orbit.

Here is the thesis for $PL based strictly on the fundamentals and the unique economics revealed in their 10-Ks and 10-Qs.

1. The One-to-Many Economics (The Margin Story)
This is the single most important concept in the Planet Labs bull case, and it’s buried in their Description of Business filings.

Traditional space companies (like Maxar or BlackSky) operate on a Tasking model.

- Customer wants a photo.
- Satellite moves.
- Photo taken.
- Result: 1 Unit of Cost = 1 Unit of Revenue.

Planet operates on a Monitoring model (Always-on).

The constellation scans the entire landmass of Earth daily.

The data goes into the database.

Customer A (Agriculture) buys the data.
Customer B (Defense) buys the exact same data.
Customer C (Finance) buys the exact same data.

The Unit Economics: You pay for the satellite once. You sell the same pixel infinite times. This is why their Gross Margins are expanding toward software levels (aiming for 70%+ long-term targets), vastly superior to traditional aerospace hardware margins.

2. The Unreplicable Moat: The Time Machine
In their Annual Reports, Planet highlights their proprietary archive.

Competitors are launching satellites today. Great. They can show you what the world looks like today.

But if an intelligence agency needs to know "When did China start building this runway?" or a hedge fund needs to know "How has this crop yield changed since 2018?", only Planet Labs has the answer.

They have an image of every spot on Earth, every day, going back years.

Competitor Lag: 10+ years.

Barrier to Entry: Impossible. You cannot launch a satellite today to take a picture of yesterday.

This archive is the training data for the world's geospatial AI. You cannot train a model on change-detection without historical data. $PL owns the training set.

3. Financial Stability (The Anti-SPAC)
While the space sector is littered with bankruptcies (Virgin Orbit, Astra), look at the Balance Sheet from the latest filings:

Cash & Cash Equivalents: Significant liquidity (approx ~$200M-$300M range depending on the specific quarter, usually ~30% of market cap).

Debt: Negligible to zero.

They are not desperate for cash. They are playing the long game while competitors starve.

4. The Quality of Revenue
Reviewing the Key Business Metrics in their filings reveals why this is a high-quality asset:

Recurring ACV (Annual Contract Value): Consistently >90%.
This implies their revenue is sticky. Once a government or agricultural giant integrates Planet data into their workflow, they don't churn. It becomes a utility like electricity.

Net Dollar Retention (NDR): Frequently >100%.
Existing customers aren't just staying; they are spending more every year.

5. The Sleeping Giant: Government Contracts

The 10-K highlights a shift in strategy: From Data to Solutions.

We are seeing a massive transition in US Government (USG) spending. The NRO (National Reconnaissance Office) and NGA (National Geospatial-Intelligence Agency) are moving from buying satellites to buying commercial data.

EOCL Contract: A multi-year validation by the NRO.
NASA: Renewed and expanded usage.

Planet is already embedded in the US federal ecosystem. As geopolitical tensions rise (Ukraine, Middle East, Taiwan Strait), the demand for "Daily, Global Transparency" becomes inelastic.

The Valuation Disconnect

The market treats $PL like a speculative de-SPAC. But the filings show a company with:

SaaS metrics (90%+ recurring revenue).
Tech monopoly (Daily scan).
Fortress balance sheet (High cash, no debt).

The Catalyst: The launch of the Pelican (high-res) and Tanager (hyperspectral) constellations.

Pelican closes the resolution gap with Maxar.

Tanager opens a new market in carbon/methane detection (ESG compliance).

Summary:
You are buying a monopoly on daily Earth data for roughly the price of the cash on their books plus a small premium. When the market realizes this is an AI/Data play and not a Hardware play, the multiple expansion will be violent.

Note: Not financial advice, do your own research.


Summary: Endorses GOOGL as the best Mag7 company; bullish on its AI stack dominance.

industry='Internet Content & Information'

$GOOGL From defense to offense, from “Search is Dead” to  “AI King”
Across the AI stack:

✅Google DCs
✅Google TPUs
✅Google Cloud
✅Google Gemini
✅Google A2A Protocol https://t.co/ITLAr8BTeR


Summary: Bullish HIMS longer-term: lab launch deepens moat during sell-off, setting up recovery for patient investors despite near-term weakness.

$HIMS has been taken to the woodshed lately, and frankly, a lab launch won't fix broken sentiment overnight. The market is currently trading on fear, not fundamentals.

However, this is exactly what you want to see while the price collapses: Execution.

While the street panics, $HIMS is deepening its moat. It probably won't stop the bleeding today, but it sets up a massive recovery play for those with patience.

🚨 BREAKING: $HIMS LAUNCHES LAB TESTING

- Up to 120 biomarkers
- 10 vital health areas
- Starting at $199/year https://t.co/yARZObrTfj


Summary: Bullish CIFR: already near neutral PT but sees material upside if full potential is realized.

$CIFR almost reaching neutral price target already. If they reach full potential, they can go way higher!

$CIFR has seen massive valuation growth this year, riding the AI datacenter wave. After a recent pullback from its highs, many investors are asking if this is a dip-buying opportunity or a signal of underlying risk.

Let's dig into $CIFR 🧵 https://t.co/yoPDkBDcxv


Summary: Initiated long SK Hynix at €487; thesis: monopolistic HBM share, AI structural tailwind, profoundly undervalued at 5.2x fwd P/E vs 25%+ FCF growth.

I bought 4 new shares today. The first buy I want to share with you is SK Hynix. I bought the stock at €487 at the Frankfurt stock exchange today.

I believe that Hynix is a foundational AI infrastructure play that the broader market is still severely mispricing.

Generative AI training requires massive, rapid data ingestion, and right now, logic processors are quite literally starving without stacked memory.

What do they do?

SK Hynix is the indispensable backbone of Nvidia's AI accelerators, commanding a monopolistic 62 percent global market share in High-Bandwidth Memory.

They established this massive lead through a proprietary packaging process called MR-MUF. This technology dissipates heat drastically better than the processes used by rivals like Samsung, resulting in far fewer defects.

Because manufacturing and installing the microscopic through-silicon via production lines takes 18 to 24 months, new capacity cannot simply be spun up overnight. Consequently, SK Hynix’s entire production capacity is fully booked and completely sold out through 2026.

How do they make money?

This severe supply constraint has forced a highly profitable evolution. SK Hynix has transitioned from a cyclical commodity memory manufacturer into a full-stack AI memory provider.

They are now selling highly customized, premium HBM modules directly to hyperscalers under long-term, forward-booked supply agreements.

The financials reflect this dominance. They are generating record-breaking numbers, boasting an incredible 49% operating profit margin and sitting on a cash pile of $19.2 billion.

What is my business case?

The core investment case rests on a massive valuation asymmetry. Wall Street is terrified of historical memory cycles and is pricing SK Hynix as a volatile commodity facing an imminent bust.

The stock is currently trading at a severely distressed Next Twelve Months Forward P/E of just 5.2x. Running a reverse discounted cash flow analysis reveals that the market implies a mere 7.6% free cash flow growth rate over the next decade.

This is completely disconnected from the structural growth of the AI infrastructure buildout, which easily exceeds 25%. Because this AI expansion is a permanent structural shift rather than a fleeting cycle, the equity is profoundly undervalued and primed for multiple expansion.

What is my exit strategy?

First, I think I must closely monitor the cascading effects of the conflict in Iran on global LNG prices. A sustained spike in energy costs could severely compress SK Hynix's operating margins due to the highly power-intensive nature of semiconductor fabrication.

The other immediate risk is a severe HBM supply glut emerging in late 2026 or 2027. If new capacity from Samsung and $MU finally floods the market, it would rapidly erode SK Hynix's pricing power and margins.

Furthermore, with 40 percent of their global DRAM supply and 25 percent of their NAND output manufactured inside China, any revocation of US export licenses for advanced chipmaking tools could render a massive portion of their legacy supply chain technologically obsolete.

However, that downside is heavily priced into the current 5.2x multiple. I feel that the market is giving us a clear opportunity to buy a monopoly-like asset feeding the biggest technological shift of our decade at a distressed valuation, and the upside is simply too massive to ignore.

Note: This are my own financial decisions and no financial advice. Do your own research.

SK Hynix still looks like a clear buying opportunity to me.

This graph perfectly shows why. Despite their stock price running up, their earnings growth is so explosive that the valuation keeps compressing.

Every time the Forward P/E spikes, they report massive revenues and https://t.co/y0XK63ycm3


Summary: Long IREN: 4.5GW power pipeline is a strategic moat; monetizing remaining 90% capacity should drive a re-rating as critical AI infrastructure.

@moninvestor Power access is the bottleneck for AI scaling. $IREN's 4.5GW pipeline is a massive strategic moat. As they monetize the remaining 90%, the market should re-rate them as critical infrastructure.

$IREN AI needs power. A lot of it.

Global data center electricity demand is set to quadruple over the next decade. The companies that own the power infrastructure are going to win this cycle.

IREN controls 4.5 GW of power capacity and has only monetized around 10% of it so far. https://t.co/I6vmzcNRUD


Summary: Bullish PL; ceiling not in sight after 6x gain, more upside expected.

$PL now my second 6-bagger. The ceiling not in sight if you ask me. https://t.co/CdoJOivBLt


Summary: Long HIMS with a $390 long-term price target.

@zarieinvests $HIMS can easily go to $390 long-term! https://t.co/yKhWe8nTGA

My new $HIMS end of year Price Target 👇 https://t.co/Qi59Va0HEQ


Summary: Long HIMS long-term; recent CEO-driven 24% drop is short-term noise for patient investors.

@Mr_Derivatives Long-term is still very bullish for $HIMS. The patient investor can benefit from this short-term noise.

$HIMS is a cult stock. It had that look it wanted to test ATH's 3 days ago. Then the CEO came out and ruined it for the shareholders (IYKYK). Stock got slammed 24% peak to trough. Sure macro and broader markets had some play on the name too, but not a good look what the CEO did.


Summary: Bullish APP despite 9% post-earnings dip; blowout results and AI scaling into e-commerce suggest dip is temporary profit-taking.

$APP down 9% after a great Q4 double beat.

AppLovin’s latest report confirms its transformation into an AI software powerhouse. Revenue surged 66% year-over-year, while profits nearly doubled, fueled by the extreme efficiency of its Axon engine. The company is now operating at elite software levels, guiding for a massive 84% profit margin next quarter.

Despite these blowout results and a multi-billion dollar share buyback program, the stock dipped 9% following the news. This likely stems from a priced for perfection valuation after its massive run-up in 2025. Investors are taking profits, even as the core business, now a high-cash-flow, pure-play tech platform, proves its ability to scale beyond gaming into e-commerce. The engine is humming, the market is just catching its breath.


Summary: Bullish OKTA on profitability trajectory despite cautious revenue guidance; strong cash flow and AI agent expansion.

$OKTA delivered a strong double beat, easily surpassing Wall Street's revenue and profit expectations.

They generated excellent cash flow and are smartly expanding their platform to secure AI agents.

Okta’s forecast is highly cautious. Management expects revenue growth to decelerate to just 9% next year. This slowdown is tied to tough economic conditions and a strategic shift to hand off professional services to partners, a move that temporarily eats into top-line sales.

Ultimately, investors are worried about the tepid growth outlook, on the other hand Okta is becoming a much more profitable machine.


Summary: Long LITE as standout alpha play on Google OCS architecture shielding it from transceiver commoditization.

@aleabitoreddit Insightful mapping. $LITE is the standout alpha here since $GOOGL OCS architecture prevents the commoditization seen in standard transceivers. Betting on infrastructure divergence is a smart strategy.

Analysis of the $GOOGL TPU v7 Ironwood Suppliers.

Here's the list of what comapnies are the most materially impacted by the Google's TPU buildout.

+ the TPU stock I'm taking a position on.

[Critical] Design/IP:
- Broadcom [ $AVGO ]: co-designs and implements Google’s TPU https://t.co/mYu8ZDoiMI


Summary: All three AI compute stocks (NBIS, IREN, CIFR) will win based on NVDA growth projections.

It does not really matter if you choose $NBIS, $IREN of $CIFR.

According to the $NVDA projections, they will all win 📈 https://t.co/Lxs9JOzMbm


Summary: Bought IREN on the dip today; live long position.

@moninvestor We bought the $IREN dip today 👌🏼

Extremely BULLISH on $IREN, $CIFR & $NBIS.


Summary: Remains very bullish on cybersecurity; DDOG, CRWD, NET, ZS all posting 36%+ CAGR quarter after quarter.

Just a chart of $DDOG, $CRWD, $NET, and $ZS growing quarter after quarter with a CAGR of more than 36%.

I remain very bullish on the cybersecurity sector. https://t.co/QGnvKAwVVS


Summary: Author substitutes FLNC for ONDS, endorsing IREN, HIMS, and FLNC as top portfolio picks for 2026.

@moninvestor I’m more $IREN, $HIMS and $FLNC

The three stocks that I believe should be in everyone’s portfolio:

🥇 $IREN – AI Data Centers
🥈 $HIMS – Longevity & Healthcare
🥉 $ONDS – Drones & Robotics

Each one sits at the center of what will be the strongest sectors in 2026.


Summary: Endorses PGY as heavily overlooked, implying upside from current levels.

@oguzerkan $PGY is heavily overlooked in this market

$PGY is one of the most obvious opportunities here.

Institutions have been slowly but steadily building their positions since Q1. The company is clearly regaining their trust.

There is still a way to go, but 15x forward earnings is a no brainer for this stock.

Long $PGY. https://t.co/elOBAcebHi


Summary: Bullish on CRWD, NET, DDOG; cybersecurity wave shows no sign of cresting.

Sometimes the wave isn't very hard to spot... This cybersecurity wave shows no sign of cresting anytime soon.
$CRWD, $NET, $DDOG https://t.co/Y4zmRbYoio


today's multiple looks like a compelling entry point for a high quality asset in the payment space

Summary: Long Adyen: valuation compression doesn't reflect intact long-term thesis; 24x forward EV/EBIT is a compelling entry.

@fiscal_ai The multiple has compressed but the long-term thesis hasn’t. With their continued expansion into unified commerce and platform solitions, today’s multiple looks like a compelling entry point for a high quality asset in the payment space.

Adyen is now trading near its cheapest forward multiple ever.

Forward EV/EBIT: 24x

$ADYEN https://t.co/tMxhd0j5N5


Summary: Bullish GOOGL on Waymo capital raise; author sees Google dominating autonomous vehicles, AI, and space.

Waymo to raise capital. $GOOGL is winning every race at the moment. They will dominate the streets, AI and Space.

$GOOGL Waymo is reportedly in talks to raise capital at a $100B valuation

https://t.co/dlKBVv3CGk


Summary: Bullish on CIFR, seeing significant upside potential.

@StockSavvyShay $CIFR has a huge potential https://t.co/VVXpP5inaL

People see a couple red days and act like the AI build-out is cancelled.

This is a multi-trillion dollar infrastructure cycle that will run for years. If that’s the reaction then I’ll gladly take the other side.

I added $NBIS, $IREN & $CIFR this week.


$PLTR will keep on growing, you can't stop them. Back to $200 soon.

Summary: Bullish PLTR on Navy $448M contract momentum; targets $200.

@amitisinvesting $PLTR will keep on growing, you can’t stop them. Back to $200 soon.

$PLTR

BREAKING: The US Navy has announced a $448 million strategic investment in the Shipbuilding Operating System (Ship OS) to accelerate the adoption of artificial intelligence and autonomy technologies across the industrial base.

Ships OS will leverage Palantir’s software to https://t.co/n01kg1CmW2


Summary: Bullish GM: underlying business profitable, raised dividend + $6B buyback, 2026 guidance signals restructuring is behind them.

$GM just reported a mixed Q4 result. They have beaten EPS expectations but missed the Revenue guidance. The market likes the 2026 guidance though as the stock is currently up 4.5% in pre-market 🟢

While the company reported a $3.3 billion loss for the fourth quarter, this was driven entirely by a huge $7.2 billion charge to scale back its electric vehicle plans. $GM is proactively cutting EV capacity to match slower consumer demand and changing U.S. government policies.

Crucially, the underlying business remains incredibly profitable. Management is so confident in GM's cash generation that they raised the dividend and announced a fresh $6 billion share buyback. Looking ahead to 2026, $GM forecasts a return to strong growth with expected operating profits of up to $15 billion, signaling that the painful restructuring is largely behind them.


Summary: Continuing to buy IREN; AI thesis stronger than ever.

@Agrippa_Inv Agreed. The AI thesis is stronger than ever. I will keep buying $IREN at these levels as well.

Bought some more $IREN today ✅

Ironically, I'm more bullish on $IREN today than I was when I first entered at $4.8 in May 2024.

The main difference now is that:

1) Over the past 18 months I've spent thousands of hours analyzing and covering this ticker (literally thousands).


Summary: Expects TSLA to finish year strong, bullish into year-end.

@darkminer $TSLA will do great year-end 👌🏼 don’t know for next year though

Just looking at some data today with $TSLA 's historical performance in December

10 out of the last 16 years have been green
Median return of +2.16%
Average of + 1.91% return
Recent trend: 2023, 2024 & now 2025 are green

Do you think we finish up the year green?


Summary: Expects AVGO great earnings to reverse negative AI trade sentiment.

@SmartflowFi Not at the moment no, I think $AVGO will have great earnings tonight and will turn the sentiment around.

@Kaizen_Investor The fractures we’re seeing in the AI trade - interesting

Is anything you’re seeing in the macro changing how you’re going about investing right now?


$PLTR already played a huge part in the war. Their software is too good.

Summary: Bullish PLTR on its demonstrated wartime software capabilities being too good.

I’m against war. Every war. But as an investor, you have to navigate the world as it actually is, not as you want it to be.

Geopolitical conflicts happen, and when they do, you need to prepare your portfolio. Here are the companies positioned to benefit:

$PLTR: AI data https://t.co/GoISIrvQje


Summary: Expects HIMS to break above $41 resistance with a final swing upward.

@Mr_Derivatives They will, most volatile stock of 2025. They will probably go for a last swing upwards

$HIMS Bulls need to breakout above this $41ish area of resistance and then we got something here... https://t.co/Z4kcAiqWPA


Summary: Bullish HIMS as top telehealth platform to capitalize on GLP-1 expansion; broadly bullish pharma/GLP-1 sector including NVO and LLY on patent expiry driving volume.

Made a post about it last night if you want the full story. Also commented on your $NVO post why I’m bullish in the whole pharma/GLP-1 sector.

In short GLP-1 is not only an obesity drug, it is great for everyone’s health in general. It significantly reduces the risk of strokes, heart attacks, dementia, Parkinson and so on. The only reason that we don’t all take a daily GLP-1 pill is because of the production limits of $NVO and $LLY. Once the first patents fall off, I expect way more cheaper versions of GLP-1. It won’t matter if one or the other is a bit better for weightloss, as it will be just another side affect of GLP-1.

Because of the production limits of GLP-1 atm, those are only available on prescription for the people who really need it. Once GLP-1 is widely available, prescription will fall off.

I think a platform like $HIMS can really capitalise on this pivot. As they have the most telehealth customers and will join this ride. No matter the brand, best effect against strokes/ weightloss, they can sell it. No matter the brand.

Can’t argue on the management though.

@Kaizen_Investor I just don't see a sustainable moat, i don't like the fact they were/are so heavily related to compounded GLP1-s and I also do not like management.

You?


I'm bullish in the whole pharma/GLP-1 sector


Summary: Bullish NVO on Wegovy pill demand boom; bullish AMZN as big winner from Amazon Pharmacy distribution deal.

Highly anticipated news. $HIMS moved to other high groth verticals the moment the deal with $NVO collapsed.

Still I expect the $NVO pill to boom. It would have brought loads of customers to the platfom and would generate easy free cash flow. Big win for $AMZN.

🚨 BREAKING: AMAZON PHARMACY TO START SELLING NOVO NORDISK'S WEGOVY PILL

- $25/mo on insurance plans
- $149/mo cash-pay option
- free shipping to all 50 states, same-day delivery available to ~half of customers

$HIMS $NVO $LLY $AMZN https://t.co/Pq76GdDzc6


Summary: Bullish BTC: Wall Street structurally incentivized to protect and grow Bitcoin as a revenue engine.

@StockMKTNewz Bitcoin is now a structural revenue engine that Wall Street is financially incentivized to protect and expand

BlackRock’s bitcoin ETFs have reportedly become the firm’s most profitable product line - CoinDesk


Summary: Endorses NBIS as one of the best opportunities on the market, implicitly long on the ARR doubling trajectory laid out in parent.

@daniel_koss One of the best opportunities on the market atm

$NBIS growth for the slow people on X:

Last quarter: ~$500M ARR ✅

They will DOUBLE ARR to ~$1B this quarter / by end of 2025 📈

In the first quarter of 2026, they will DOUBLE again to ~$2B ARR 📈

During 2026 they will then DOUBLE again to ~$4B ARR 📈

And guess what


Summary: Bullish GOOGL: TPU-driven margin moat and vertical integration create capital efficiency the market is undervaluing.

@StockSavvyShay @fiscal_ai The "margin moat" provided by TPUs is critical. While competitors face margin compression via hardware costs, $GOOGL optimizes unit economics. This vertical integration creates a capital efficiency advantage that the current valuation ignores.

$GOOGL deserves to be valued like a ~$4T company because it is the only player that controls every layer of the AI stack & compounds them inside one ecosystem.

AI Silicon
• Google builds & trains on its own silicon which means TPUs remove the $NVDA markup that every other https://t.co/JCSkkY88QD


Summary: Top 3 picks for 2026: long HIMS, IREN, and FLNC.

The Kaizen Portfolio ends up 45.3% this year 🟢

My best performing stocks in 2025
$PL: +399%
$RKLB: +248%
$HOOD: +235%
$PLTR: +138%
$IONQ: +100%

My top 3 picks for 2026
1. $HIMS
2. $IREN
3. $FLNC

Enjoy new years eve, I'm looking forward to learn, invest and grow together🚀 https://t.co/RSkdH1eZtR


Summary: Bullish IREN, NBIS, CIFR as ideally placed to meet hyperscalers' immediate power/compute needs vs speculative space-based datacenters.

@StockSavvyShay Hyperscalers need power now, although datacenters in space in a real theoretical possibility it won’t solve our problem at this moment.

The theory is fascinating, the reality is that we need the power asap and $IREN, $NBIS and $CIFR are ideally placed to deliver.

As many of you know I’ve been a permabull on the space economy for years and have held $RKLB & $ASTS since 2023.

But we need to stop pretending that space-based data centers somehow make AI-utility names like $IREN, $CIFR, $CRWV or $NBIS obsolete since orbital compute is


I'm heavily buying $IREN at these prices

Summary: Actively buying IREN at current prices (~$36.5); decisive bullish stance.

@CaesarCapitalz I’m heavily buying $IREN at these prices

I already own a considerable amount of $NBIS shares, bought at an average cost of $24.22 per share, but I’ve considered buying other AI neo-cloud stocks lately.

Based on today’s prices, which one would you say is the best opportunity and why?

$IREN at $36.5
$CIFR at $14.9


Summary: Bullish AMPX on capital-light model, SaaS-level operating leverage, recurring battery replacement revenue, and un-priced defense contract upside above conservative $125M+ 2026 guidance.

Great summary from @SJCapitalInvest on the $AMPX earnings call.

I just want to add some extra points on why I'm very bullish on the company, mostly on the production efficiency side.

The Capital-Light Masterstroke: S&J mentions the current business is working, but it's important to add how efficiently it's working. By terminating the $110M Colorado mega-factory lease and shifting to contract manufacturing, Amprius entirely de-risked their balance sheet. They also officially terminated their ATM (At-The-Market) equity offering. Dilution risk is off the table, and cash is preserved for scaling.

Elite Operating Leverage: Because they aren't bogged down building their own factories, management noted they are tracking to generate over $1 million in revenue per employee as they cross the $100M run rate. That is SaaS-level operational efficiency inside a hardware company, and it proves the scalability of their model.

The Recurring Revenue: Building on S&J's point about robotics and drones: these industries burn through batteries. Management highlighted that the replacement cycle for these applications will eventually be larger than the initial battery sale. This creates a high-margin, compounding recurring revenue stream that traditional EV car battery makers don't get.

Massive Un-Modeled Defense Upside: S&J is right that the military is guiding them on NDAA compliance, but the near-term financial impact is still largely un-priced. Amprius's guidance of $125M+ for 2026 is explicitly conservative and does not include potential massive upside from near-term U.S. defense contracts (like the current drone dominance program).


Cisco's core networking business is growing at its fastest pace in years. By raising their full-year forecast, management signaled that the pivot to AI is well underway

Summary: Bullish CSCO despite 2% drop; record revenue, AI orders surging, fastest networking growth in years, full-year forecast raised.

$CSCO down 2% after a solid Q4 double beat.

Cisco delivered a standout quarter with record revenue of $15.3 billion. The highlight was a massive jump in AI infrastructure orders, hitting $2.1 billion, alongside a long-awaited refresh as companies upgrade office networks.

The weak spot was a 4% decline in security sales and a cautious outlook that accounts for potential new trade tariffs. Despite the minor slip, Cisco’s core networking business is growing at its fastest pace in years.

By raising their full-year forecast, management signaled that the pivot to AI is well underway, even if the market is pausing to digest the mixed security results and geopolitical uncertainty.


If you are bullish on the drone industry, you simply can't forget $AMPX

Summary: Long AMPX as an overlooked drone battery supplier building best-in-class lithium-silicon batteries and in talks with all major drone companies.

Most investors still don’t mention $AMPX when talking about the drone industry.

$AMPX is building the best drone battery, a lithium-ion battery with silicon anode.

Last week they mentioned that they are talking with every possible drone company to supply batteries.

If you are bullish on the drone industry, you simply can’t forget $AMPX.

Claude reportedly helped the Pentagon identify targets in both the Maduro Venezuela raid and the Khamenei Iran strike.

The real shift is that intelligence is becoming AI-driven while execution is increasingly drone-based creating an ecosystem that looks like this:

• $UAVS https://t.co/mZnJ6FaaNm


Summary: Long-term bullish on AMPX; technical breakout above $10.61 would clear Fib 38.2, 100SMA, and 50SMA resistances simultaneously.

$AMPX with an important push today. If they can finish above $10.61, they beat the Fib. 38.2, 100SMA, and 50SMA resistances in 1 day.

I'm a long-term investor and very bullish on $AMPX, but always great to see the chart following the thesis. https://t.co/kyxUQZTvq7


Summary: Expects BTC to recover above entry price soon.

How is #Bitcoin doing in my portfolio?

Price (Dec 11, 2025): $90,206
My holdings: 0.15 $BTC
My entry price: $102,677
24h performance: -0,01% (−$0,81)
December performance: -0,01%

Overall performance: -12,28% (−$1.939) https://t.co/SOOtMdEyzX


Summary: Bullish on space economy; expects ASTS, RKLB, and PL to surge.

@StockSavvyShay The space economy is just getting started. Companies like $ASTS, $RKLB, and $PL will surge.

$ASTS LOCKS IN COMMERCIAL DEAL WITH $VZ TO BRING SATELLITE-BASED CELL COVERAGE ACROSS THE U.S. https://t.co/Yb3S4e0ORZ


I'm keeping them all for now, I think they got a great future ahead

Summary: Holding HOOD, PLTR, PL long-term; prefers AMPX over ONDS for drone industry exposure.

@SJCapitalInvest I got $HOOD, $PLTR and $PL all in my portfolio. Got them all quite early (Hood: $34, PLTR: $30 and PL: $4). I’m keeping them all for now, I think they got a great future ahead. I rather own $AMPX than $ONDS for the drone industry.


I rather own $AMPX than $ONDS for the drone industry


Summary: Bullish ALAB post-earnings: double beat on explosive AI connectivity demand + strong Q4 guidance signal durable momentum.

$ALAB reported a strong Q3 double beat 🟢

Beat is driven by explosive, accelerating demand for its AI infrastructure connectivity solutions. The company also issued strong Q4 guidance, signaling continued momentum.

Stock is up 2% after the earnings 📈 https://t.co/A8PANHpXaq

$ALAB will report earnings tonight.

Investors are focused on the Aries (PCIe 6) retimer ramp for AI GPUs and the customer pipeline for their new CXL (Leo) memory solutions. Also listening for any color on Cloud Titan spending and market share.

EPS est. $0.39
Rev est. $206M https://t.co/RinqGXr2Sm


Summary: Avoid EOSE: management missing own targets, catastrophic cash burn, unproven manufacturing execution make it uninvestable at current levels.

$EOSE completely missed earnings today. Dropping 38% as a result. Here is my take on the company.

The Opportunity

$EOSE is an American manufacturer that designs and builds stationary, long-duration battery energy storage systems primarily for utility, commercial, and industrial applications.

Eos uses a proprietary Znyth aqueous zinc-halide chemistry that is completely non-flammable and non-toxic.  Because AI hyperscale data centers require massive, uninterrupted power without the severe fire risks and zoning hurdles of traditional lithium-ion batteries, Eos is uniquely positioned to supply this booming sector.

By sourcing 94% of their materials (like bulk zinc and titanium) within the United States, they are shielded from global supply chain shocks and perfectly positioned to harvest lucrative government subsidies.

The Risk

Despite the explosive revenue growth, $EOSE is losing money on every single battery it sells. They ended December 2025 with a gross margin of -93.83% and a free cash flow margin of -129.73%. They are burning cash at a staggering rate and absolutely must cross the gross margin breakeven point by late 2026 or 2027 to survive long-term.

To keep their operations running and retain elite engineering talent without draining all their cash, management relies heavily on Stock-Based Compensation (SBC). In 2025, non-cash items (mostly SBC) accounted for a staggering $746.8 million of their net loss. This acts as a permanent, ongoing drag on the value of the shares you hold.

The company's future hinges entirely on Project AMAZE, their aggressive plan to scale robotic manufacturing to an 8 gigawatt-hour annual capacity by 2027.  Analysts warn there is zero margin for error. Any minor supply chain bottleneck or failure in automated robotic cycle times will result in catastrophic cash burn.

Eos has a history of manufacturing struggles, including a flawed early strategy in China and a painful, costly transition from their Gen 2.3 to Z3 modules that resulted in millions of dollars in write-downs. Furthermore, traditional lithium-ion still holds 70% of the market. If global lithium prices crash, Eos's cost advantages could evaporate overnight.

My conclusion

Ultimately, despite the undeniable potential of their zinc-halide technology in the AI and renewable energy sectors, I wouldn't buy $EOSE at this moment.

The transition from a promising R&D concept to a reliable commercial manufacturer requires a level of flawless execution that management has simply not demonstrated.

This quarter, they actively missed their own full-year revenue expectations and admitted to a critical five-week delay in hitting their 2 gigawatt-hour production capacity milestone.

When a company is in such a fragile, capital-intensive phase of scaling, these are not just minor hiccups but they are glaring red flags that erode trust in leadership's ability to deliver on their aggressive operational roadmaps.

Not financial advice, just my opinion.


investors hit the panic button over two main issues… guidance is surprisingly weak… sudden leadership exodus… screams execution risk to investors

Summary: Bearish MDB: weak sequential guidance + top sales leadership departures signal execution risk justifying the 21% drop.

$MDB down 21% despite a strong double beat.

While MongoDB crushed Q4 with 27% growth and fantastic profit margins, investors hit the panic button over two main issues.

First, their future guidance is surprisingly weak. They just reported $695 million in quarterly revenue, but expect next quarter to drop to around $660 million. When a high-flying tech company predicts shrinking sequential sales, Wall Street runs.

Second, there is a sudden leadership exodus. Both the Chief Revenue Officer and the President of Field Operations are leaving. Losing your top sales engines while forecasting a slowdown screams execution risk to investors.


Summary: Bullish CRWD as one of the best businesses to own in cybersecurity.

$CRWD getting the recognition it deserves. One of the best businesses to own in the cybersecurity wave.

Proud to be named one of the 10 Most Disruptive Companies in AI by @FastCompany!

This recognition reinforces what our customers already know: CrowdStrike isn't just participating in the AI revolution. We're securing it.

https://t.co/RoDUg5RXMB


Summary: Long HIMS on NVO lawsuit drop; author added shares and sees HIMS ideally positioned for next pharma revolution.

Huge news on $HIMS!

Looks like $NVO dropped the lawsuit and HIMS will sell Novo GLP-1 products again.

Huge win for both parties.

Very happy I added some shares in the last couple of weeks.

I keep repeating: they are ideally positioned for the next pharma revolution. https://t.co/bItNhUofIu


Summary: Picks IREN and RKLB as buys from the pullback list.

@YodaStockInvest I buy $IREN, $RKLB and $RKLB

Which stock that pulled back is the best buy today?
1. $AMD at $217
2. $HIMS at $39
3. $FUBO at $3
4. $NBIS at $94
5. $IREN at $47
6. $CIFR at $20
7. $OSCR at $17
8. $ASTS at $56
9. $RKLB at $42
10. $DUOL at $191

I'm 62% in $AMD, that's my biggest bet.


Summary: Bullish NVDA: HBM4 premium pricing locks in performance lead, starves rivals, and confirms pricing power — a strategic moat.

$NVDA paying a premium to secure the best HBM4 supply first. This move locks in their Blackwell/Rubin performance lead, starves rivals of top-tier memory, and proves they can pass any cost on to customers. A strategic moat-building cost.

Local Seoul reports suggest that SK hynix has finalized HBM4 pricing for next year with $NVDA at roughly $560 per chip, which is over 50% higher than HBM3E (~$370) and over 10% higher than what some expert expected. https://t.co/TMarGN9aom


Summary: Endorses both TE and ZETA as great adds heading into 2026; bullish on both positions.

@BlackPantherCap $TE and $ZETA are great adds 👌🏼 portfolio will do great in 2026 📈

→ PORTFOLIO UPDATE & REFLECTIONS:

Entering 2026, the AI infrastructure and energy names have continued their volatile ride, yet the underlying bottlenecks in power and compute remain as tight as ever.

I initiated two positions during the recent dips:

$TE is scaling U.S. solar https://t.co/OJcz7rOfU3


Summary: Long IREN, CIFR, and NBIS as the plays on energy, the biggest bottleneck of the AI revolution.

Energy is the biggest bottleneck of this AI revolution.

$IREN, $CIFR and $NBIS are ideally positioned to deliver this energy.

That is all you need to remember.


Summary: Endorses the government's INTC deal as a great outcome; implied bullish on INTC.

@unusual_whales The government made a great deal with buying $INTC

Howard Lutnick on the Intel, $INTC, deal:

How much money have we made? $40 billion, 3 months... The US is entitled to 10% of their company... the chairman says: you have a deal!" https://t.co/HAJPuL5usV


Summary: Names HIMS, IREN, FLNC, and PL as best 5x+ opportunities for 2026.

@YodaStockInvest $HIMS, $IREN, $FLNC, $PL

Let’s start out 2026 by helping each other find some 5x opportunities!

Name your best 5x+ stock.
I’ll start with 10 picks:
$HIMS
$SOFI
$NBIS
$IREN
$AMD
$FUBO
$KRKNF / $PNG.V (Kraken Robotics)
$LMND
$RKLB
$ASTS


a massive new catalyst has emerged: AI smart eyewear. These devices need tiny, powerful batteries, and Enovix is already seeing early orders. their silicon tech still holds 12% more energy than rivals, protecting their moat

Summary: Bullish ENVX: AI eyewear as new catalyst with early orders, durable moat via 12% energy-density advantage over rivals.

$ENVX delivered a solid quarter, popping 2% on a double beat.

Beyond the numbers, they are successfully shifting from research to real-world production. While smartphone battery approvals are still pending final lifespan tests, a massive new catalyst has emerged: AI smart eyewear. These devices need tiny, powerful batteries, and Enovix is already seeing early orders.

At their Malaysia factory, the only major speedbump is how fast they can cut battery materials, though they have a mechanical backup plan ready. Crucially, their silicon tech still holds 12% more energy than rivals, protecting their moat.


posts a strong double-beat, hitting record steel shipments as favorable trade rulings create a "significant tailwind"

Summary: Bullish STLD on double-beat, record shipments, trade tailwinds, and ahead-of-schedule milestones in aluminum and biocarbon.

$STLD posts a strong double-beat, hitting record steel shipments as favorable trade rulings create a "significant tailwind."🟢

The company also achieved major milestones, successfully producing its first aluminum flat-rolled products and biocarbon materials ahead of schedule. https://t.co/nml6CKhycm


Summary: Long IREN: 2 GW power-ready capacity at Sweetwater is a strategic moat with $36B deal potential for hyperscalers.

@HyperTechInvest That 2 GW of power-ready capacity is a strategic moat. Hyperscalers are starving for this exact scale, making Sweetwater a magnet for a transformative deal. The $36B potential is clear for $IREN

A few months ago, I changed my mind on $IREN

Today, I still believe $IREN is one of the best opportunities

2 GW of approved capacity in their Sweetwater data center is massive

A deal for that capacity could be an industry game changer

Even if they only did colocation, at $2 https://t.co/QsEedGQ0OC


Summary: Bullish NEE: best-ever renewables year, nuclear restart deal with Google, extended growth forecasts through 2035 capitalizing on clean energy demand.

$NEE with a mixed Q4 again. They have beaten the EPS estimates but missed revenue estimates again. Stock is currently flat after these earnings.

A standout highlight was the agreement to restart the Duane Arnold nuclear plant to supply carbon-free power for $GOOGL, signaling massive demand from the tech sector.

The company’s renewables business had its best year ever, adding 13.5 gigawatts of new projects to its development pipeline. Simultaneously, its Florida utility secured a stable four-year rate plan to fund up to $100 billion in infrastructure upgrades.

With extended growth forecasts through 2035, $NEE effectively demonstrated it is capitalizing on the surging need for reliable, clean electricity across the US economy.


Summary: Long TMDX as shareholder; bullish on sticky NOP scaling, aviation moat, kidney TAM expansion in 2026, and European NOP rollout.

As an $TMDX shareholder, I'm really happy about last quarter. I just went through the whole report and here are my thoughts on Q4 and 2025 in general for Transmedics.

1. The National OCS Program (NOP) is highly sticky and scaling

The core thesis for TransMedics is that transplant centers don't just want a machine, they want a turnkey service. The numbers prove this out. Q4 revenue hit $160.8 million (up 32% YoY), driving full-year case volumes to 5,139 which is a massive 38% increase. This growth is primarily fueled by the utilization of the Organ Care System (OCS) for Liver and Heart, seamlessly bundled with their NOP logistics.

2. Widening the Aviation and Logistics Moat

$TMDX isn't just selling boxes, they are controlling the entire chain of custody for highly perishable assets. They ended 2025 with 22 owned aircraft. This in-house fleet removes reliance on fractured third-party charters, ensuring organs get to patients faster while capturing the logistics revenue.

Furthermore, securing a long-term lease for a new global headquarters and adjacent land in Somerville, Mass., signals they are building out a fully integrated campus to scale this operation over the next decade.

3. Setting the Stage for Massive TAM Expansion (Kidney)

While heart, lung, and liver are driving current revenues, kidney transplants represent the largest market by volume. Management explicitly noted they are preparing for the clinical launch of the OCS Kidney program in 2026. Securing FDA approval for the OCS Enhance Heart and Denovo Lung trials also proves their regulatory engine continues to hum, setting up the next generation of clinical indications.

4. Aggressive European Restructuring

The US playbook is working, and now they are exporting it. Appointing Tamer Khayal, M.D., to the new role of SVP of International specifically to drive the NOP model across Europe shows a strategic pivot. Historically, European adoption of OCS was held back by the lack of the turnkey NOP service model.

Replicating their logistics success in Europe opens up a massive, underpenetrated secondary market.

$TMDX delivered a stellar report, sending the stock up 9%.

Their organ-in-a-box tech and in-house aviation network are transforming transplant logistics. Revenue jumped 32% this quarter, fueled by high demand for their transport services and a growing fleet of 22 planes. https://t.co/EUqhUBjT8R


Summary: Highest-conviction long on PL; believes much more upside remains after post-earnings 20% pop.

What a lovely morning for $PL https://t.co/MzulwZaLWP

$PL now up 20% after earnings tonight. It is my highest conviction stock since I bought them at $4 earlier this year. I believe there is still much more room to run.

If you want to know more about $PL 👇


their massive $7.3 billion backlog, a 50% jump from last year, which guarantees a highly visible pipeline of future work... management issuing a highly optimistic profit forecast for 2026, the market clearly agrees this growth engine has plenty of runway left

Summary: Long BWXT on record backlog ($7.3B, +50% YoY), successful acquisitions, and optimistic 2026 profit guidance with visible runway ahead.

$BWXT shares climbed 5% following a blockbuster report that proves their strategy is paying off.

The company delivered a record year, fueled by booming demand in both national security and commercial nuclear power. The standout metric is their massive $7.3 billion backlog, a 50% jump from last year, which guarantees a highly visible pipeline of future work.

Furthermore, recent acquisitions are successfully expanding their scale and driving fresh revenue across the board. With management issuing a highly optimistic profit forecast for 2026, the market clearly agrees this growth engine has plenty of runway left.

Nuclear remains the backbone of our future energy needs.


Summary: Names HIMS as top pick for 2026; decisive long stance.

@moninvestor $HIMS is my go to pick for 2026

Given the amount of negative coverage this stock has received, you would think it would have collapsed by now.

But $HIMS is up 36% YTD. It was up more than 150% at four different points this year.

You can be a long-term investor and take advantage of the volatility, or you can https://t.co/fKn8Iqk155


$HIMS is valued like a dead company at the moment. I believe those acquisitions can be a major lever for the company and the upside is greater than the risks at these levels. I'm confident to add.

Summary: Long HIMS: valued like a dead company despite major acquisitions; upside outweighs risks, adding to position.

$HIMS market cap: $3.6B

$HIMS latest acquisitions
- Eucalyptus: $1.15B - expand global dogital health footprint
- YourBio Health: ~$100M - integrate painless needle blood testing
-Zava: $265M - Expand European operations
- MedisourceRx: ~$31M - Bolster drug manufacturing capabilities

Yes, every acquisition includes risks but $HIMS is valued like a dead company at the moment.

I believe those acquisitions can be a major lever for the company and the upside is greater than the risks at these levels. I’m confident to add.


Summary: Bullish PLTR long-term; advises holders not to worry.

@jrouldz Well done but long term bulls shouldn’t worry at all

$PLTR

laugh at technicals all you want but I did call the head & shoulders top AND THEN the support zone bottom

maybe just another coincidence 😆 but joke is on me because I didn't actually trade these setups...just holding long 😅 https://t.co/Yfisja1u4B


Summary: Long CIFR: transformed into high-growth AI infrastructure play with hyperscaler leases; power assets seen as undervalued vs data-center REITs.

$CIFR with a strong 7% move today.

The analytical case here is straightforward: Cipher has effectively transformed into a high-growth infrastructure play, locking in 15-year and 10-year leases with Tier-1 hyperscalers like AWS and Fluidstack (backed by $GOOGL).

They will be leveraging their multi-gigawatt power portfolio to serve the insatiable demand for AI compute.  Today's price action likely reflects a "sum-of-the-parts" re-rating, where investors are realizing the company's power assets are trading at a discount relative to pure-play data center REITs.


Summary: Long HIMS with targets of $100 mid-term and $390 long-term.

@NighthawkTradez $HIMS will move to $100 mid-term, $390 long-term! https://t.co/Zi7S2XlQtW

We are not the same.

$HIMS to $100 https://t.co/sJVDGd2AmX


Summary: PLTR moving to $200 soon.

$PLTR

HITING ALL TIME HIGH’S

I am up 48%

Congratulation’s to all $PLTR shareholder’s https://t.co/7jFKYdtNlN


Summary: Bullish on MSCI World index inclusion play; overhang cleared in one block = clear skies ahead.

industry='Financial Data & Stock Exchanges'

@genZinvest0r If ~22M crossed, they likely maximized the fill. Removing that overhang in one discrete liquidity event is superior to a slow drip. Clear skies ahead.

@Kaizen_Investor Agree. It’s a 4D-chess esque move for sure!

The only thing I’m torn about is whether they sold all of the shares available under the ATM or only partially utilized it. Initially I was leaning toward partial utilization, but notional reports suggest MSCI World index inflows


$FLNC is a maturing market leader dealing with the growing pains of a massive global backlog... this is an easy decision for me

Summary: Prefers FLNC over EOSE: FLNC has structural profitability, $5.5B backlog, and $1.1B liquidity vs EOSE's negative margins, near-$1B net loss, and unproven manufacturing.

My take on the production problems at $EOSE and $FLNC, and mainly, why there is a major difference.

The energy storage sector is experiencing exponential demand right now, driven by utility-scale renewable projects and the rise of power-hungry AI data centers. However, scaling up hardware production remains a capital-intensive and operationally fraught challenge.

Based on the latest quarterly filings from Fluence Energy   and Eos Energy Enterprises, both companies are facing production and margin headwinds. Yet, the nature and severity of these problems are vastly different.

Eos Energy: The Automation Struggle
Eos Energy’s Q4 2025 earnings report delivered a harsh reality check, sending the stock plummeting. While the company achieved a record $114.2 million in full-year revenue, it severely missed its Q4 revenue targets, bringing in $58 million against a forecasted $92.8 million.

The core of Eos's struggle lies in its ambitious initiative to scale its novel aqueous zinc-halide battery manufacturing.

Management pointed to significant challenges in achieving quality targets on their new automated bipolar production lines.

The inability to maintain consistent quality off the automated line has resulted in high equipment downtime, isolated supplier non-conformances, extensive product rework, and ultimately, lost revenue that missed Q4 guidance.

While $EOSE touted a margin improvement, the reality is that their 2025 gross loss was a massive $143.8 million. It currently costs Eos significantly more to build their batteries than they can sell them for.

Fluence Energy: Hiccups on a Profitable Path
Fluence’s Q1 FY2026 earnings also shocked the market, though for entirely different reasons. The company delivered a massive 154% year-over-year revenue surge to $475.2 million but saw its adjusted gross margin shrink to 5.6%, well below its 11%–13% target.

However, Fluence’s production and margin issues are tied to discrete contract execution rather than fundamental technology scaling problems.

The bulk of the margin compression was tied to $20 million in extra, project-specific costs stemming from scope and schedule changes on two non-U.S. projects.

$FLNC has also dealt with a slower-than-expected production ramp at its recently commissioned U.S. manufacturing facilities, but management noted that module production is now running ahead of plan.

Management noted that corrective actions are already in place, domestic cell supply chains are secured for the year, and they fully expect to recover the discrete contract costs from their customers.

The fundamental difference
If you look at the raw stock reactions, both companies were heavily penalized by the market following their respective earnings calls. However, a deeper look at their financial health shows that Fluence's situation is a temporary operational hurdle, while Eos is fighting a structural battle for survival.

When comparing their recent filings directly, the stark contrast in financial health becomes obvious. Fluence generated $475.2 million in revenue over its latest quarter while maintaining a positive 5.6% adjusted gross margin, backed by a robust $1.1 billion in total liquidity.

In contrast, Eos reported just $58 million in revenue for Q4 2025, falling well short of forecasts, and posted a staggering full-year net loss of $969.6 million. Eos continues to operate with deep negative gross margins and relies heavily on complex financing, equity dilution, and debt to maintain its $625 million cash position.

The distinction is clear: Fluence's products are structurally profitable. Even with a disappointing quarter, they make a gross profit on what they sell. Eos, on the other hand, is still trying to figure out how to manufacture its proprietary tech at scale without losing money on every unit that rolls off the line.

The Verdict: Why I Choose Fluence Over EOS Energy
For investors weighing the energy storage sector, Fluence offers a much more compelling and de-risked value proposition compared to Eos Energy.

Fluence is a battery-agnostic systems integrator relying primarily on proven lithium-ion technology. Their primary challenge is supply chain management and contract execution. Eos is trying to commercialize a totally new zinc-based chemistry via complex, untested automated manufacturing.

Fluence is also sitting on a record $5.5 billion backlog, which fully covers the midpoint of their entire $3.4 billion revenue guidance for fiscal 2026. Eos's backlog sits at $701.5 million, and their revenue visibility is constantly threatened by their inability to get functional product out the door on time.

Eos's massive 2025 net loss of nearly $1 billion (though largely driven by non-cash items) highlights a highly speculative business model that requires constant capital injections. Fluence operates from a position of strength with $1.1 billion in liquidity and a clear, reaffirmed line of sight toward adjusted EBITDA profitability for the year.

Ultimately, $FLNC is a maturing market leader dealing with the growing pains of a massive global backlog. $EOSE is an early-stage speculative play still trying to prove its factory can build a profitable product. With $FLNC at $2.86B market cap and $EOSE at $2B market cap, this is an easy decision for me.


$EOSE is an early-stage speculative play still trying to prove its factory can build a profitable product


Summary: Bullish AT&T on double beat, 5G/fiber bundle working, best broadband growth in a decade, $45B shareholder returns, and clear growth-focused reporting changes.

$T with a double beat in Q4. The stock is currently up 3.5% in pre-market.

Their strategy of bundling 5G mobile with fiber internet is working, driving the best broadband subscriber growth in a decade.

Management is bullish on the future, forecasting rising profits and cash flow through 2028, supported by a massive plan to return over $45 billion to shareholders via dividends and buybacks.

Crucially, AT&T is changing how it reports results to better show its value. They will now separate the growing "Advanced Connectivity" business from the shrinking "Legacy" copper network, which they plan to phase out by 2029. This transparency, combined with strategic acquisitions, signals a clear, growth-focused path ahead.


Summary: Bullish NVDA into earnings; expects a beat, and views any miss as a better buying opportunity.

@freedombill3 Morning Bill, not worried on the $NVDA earnings either. Think they will crush earnings again. If not, we can buy at even better prices.
Enjoy your monday!

Good morning, Monday 🌄🌞. A new week of opportunities, winter has finally arrived and it's taken a cold turn 🥶.

You're going to see $NVDA chatter everywhere this week.

Will it pop?
Will it drop?
Should you buy before earnings?

It's all just noise. A gamble.
Worrying about


I don't like $LULU, visited several shops in Europe and I just don't see it work. In real life it looks like a dead company.

Summary: Bearish LULU: European store visits show weak real-world demand, cheaper/better quality competition from Oysho.

I don’t like $LULU, visited several shops in Europe and I just don’t see it work. Oysho is cheaper and better quality. On paper it looks like a good company. In real life it looks like a dead company.

I’m not into crypto so would cut $MSTR and $ETH as well.

So $LULU, $MSTR and $ETH imo.

My portfolio has 8 positions.
This isn’t concentrated enough.
I need 5, but what on earth do I cut?

$TMDX, for obvious reasons no one seems interested in though. https://t.co/iEB1MJQ3Ca

$ETH & $MSTR, crypto is going higher and the mispricing is real.
https://t.co/vtPbgNo7kD https://t.co/By1EwTfEtt


Summary: Bought HIMS (digital health / GLP-1 play) and AMPX (silicon anode battery tech) this week.

@PalantirHotline $HIMS, building a scalable, high-margin digital health platform that will highly profit form the GLP-1 wave.

$AMPX, leading silicon anode battery technology for high-value markets like drones, aviation, and EV’s.

Difficult to put it in one-line 😅

Weekly performance 🩸
$HOOD -9.2%
$BMNR -8.5%

Did you buy these names this week? If not, what did you buy and why? https://t.co/4vkTW4nfDq


$AMPX, leading silicon anode battery technology for high-value markets like drones, aviation, and EV's.


Summary: Terse but decisive quality verdict on ASML as best European company; implied bullish.

industry='Semiconductor Equipment & Materials'

@StockSavvyShay $ASML is the best European company at the moment

$ASML CEO says AI demand keeps compounding as more companies design chips & AI products which pulls semiconductor equipment demand higher with it.

You can’t play in AI without hyperscaler capex & every 2–3 years the shift to a new chip generation resets the upgrade cycle. https://t.co/3Yeu1VStuo


$PL and $ASTS reaching new ATH as well. Don't miss the wave!

Summary: Bullish PL and ASTS on new ATH momentum; urging not to miss the move.

@StockSavvyShay $PL and $ASTS reaching new ATH as well. Don’t miss the wave!

$RKLB JUST CLOSED AT A NEW ALL-TIME HIGH https://t.co/tpKq3zMsaH


$PL is surfing on the AI and space-economy wave. AI is nothing without data, and $PL owns it. They snap the entire planet daily and sell that goldmine of data across industries. Becoming the backbone of AI.

Summary: Long PL: owns irreplaceable daily planetary imagery data, becoming AI's backbone; surfing AI and space-economy wave.

$PL is printing ATHs and nobody’s talking. I’ve been in since $4.

AI is nothing without data, and $PL owns it. They snap the entire planet daily and sell that goldmine of data across industries. Becoming the backbone of AI.

$PL is surfing on the AI and space-economy wave. https://t.co/CMTArCME29


$IREN isn't raising cash to fund burn rates on a non-existent business model; they are raising growth capital to fund immediate, accretive infrastructure expansion. This is a land-grab for power capacity, and $IREN is securing the hardware to monetize that power now

Summary: Bullish IREN: defends convertible raise as accretive capital allocation for AI/HPC infrastructure, not a 1999-style burn; ROIC exceeds cost of debt.

The comparison to 1999 fails when you analyze the Use of Proceeds. $IREN isn't raising cash to fund burn rates on a non-existent business model; they are raising growth capital to fund immediate, accretive infrastructure expansion.

In an asset-heavy industry like AI/HPC, financing is a tool, not a trap, provided the Return on Invested Capital  outpaces the cost of debt. With the convertible notes priced so aggressively low, institutions are clearly signaling they believe in the execution. This is a land-grab for power capacity, and $IREN is securing the hardware to monetize that power now, rather than waiting. This is textbook efficient capital allocation, not a "predatory" move.

Year of Magical Investing is back. Sell any company NOW that is doing a financing (a la IREN) or has big insider selling... Stay close here!!! No one else will call this stuff... but i have 1999-2000 encyclopedia in my head from when they still used them. Investors must be


Summary: Long POET on upside + cash floor; long MRVL as safe buy for photonics exposure via acquisitions.

Thanks Daniel, I’ve done a lot of research on photonics in the last 2 to 3 weeks as I really wanted some exposure. I’m certainly not an expert on it, like our Korean friends but I now understand the basics.

I think a lot of those stocks have heavy valuations. With $POET, I have a lot of upside and the 335M cash pile, limits the downside at the minute.

I really like the latest $MRVL acquisitions. They won’t triple any time soon but I believe it is a safe buy to find some more exposure.

@Kaizen_Investor Very solid picks. Got SK Hynix and $OUST aswell. $POET would be one of my top 3 picks in photonics but not enough research yet and Marvell is just a lil too big for my taste but probably super solid long term.


I believe it is a safe buy to find some more exposure


Summary: Still holding PL from $4; expects 10x return from current levels.

@GuyTalksEnergy I bought them at $4. Still holding. Confident it will be a 10-bagger for me.

@Kaizen_Investor Want to hear something disgusting? I bought $PL ~$3 and sold at $7. One of my biggest trading regrets..


Summary: High-conviction long HIMS as GLP-1 platform monopolist; also bullish LLY and NVO on patent-protected pricing power as supply remains constrained.

It still strikes me how wrongly investors see the GLP-1 drugs. It is not an obesity drug, it is way more than that.

Last year I shared some research on $HIMS and why I think they are ideally positioned for a huge next pharma wave. (yes, they are still down 25% since I shared the research, but it's about the thesis).

It is scientifically proven that GLP-1 helps with cardiovascular health, kidney diseases, addiction, neurological conditions, sleep apnea, fatty liver, fertility, and even more conditions.

So why is it still mainly seen as an obesity drug?

The GLP-1 production is now regulated by 2 main players, $LLY and $NVO. They both own patents that prevent other companies from starting GLP-1 production. This means that both of those companies have huge pricing power.

The pricing power is a simple supply/demand principle here. The supply is limited, so the higher the demand, the more Novo and Lilly can ask for their GLP-1 products.

Here is where the governments jump in. They also see these huge GLP-1 benefits, but want to make sure the system benefits most. Obesity is one of the most costly diseases for our healthcare system and so the governments regulate the drug only for obesity use.

How can this change?

Patents will expire and other companies will find ways to bypass the patents or create their own. Pfizer and Roche are both working on their own GLP-1 products.

In other words, the supply gets bigger -> price of the drug will come down -> and governments can ease the prescriptions.

First, governments will just widen the prescriptions to more diseases, to not let the demand side surge again. But after a couple of years, I believe that you won't need a prescription anymore.

Andrew Dudum expects competition to push prices from $1,500 / month toward $50 / month as supply grows & patents expire.

Who benefits from this change?

The one who can get the GLP-1 products to the customer. As long as the products are protected by prescriptions, $HIMS basically has a monopoly.

They will need to do everything in their power to attract as many customers as possible to the platform with this monopoly.

They will need to be the front-tier supplier/platform when prescriptions fall off. If not, it will be easy for Amazon or others to catch up.

This is why the dispute with Novo is so important. $NVO is the first company to produce a GLP-1 pill. It is super important that $HIMS brings it to the customers. Customers should create a habit of ordering from HIMS.

The price targets I set in December look out of proportion at the moment. But, I still believe in the business case. With a settlement ready between HIMS and Novo, I don't see any reason to change my business case.

$HIMS stands out as one of my highest-conviction picks for 2026. However, the stock is currently facing three distinct headwinds. Below, I outline these challenges and explain why I expect the narrative to shift significantly.

The pharma industry is undervalued right now: https://t.co/FyHw9NyFVN


The GLP-1 production is now regulated by 2 main players, $LLY and $NVO. They both own patents that prevent other companies from starting GLP-1 production. This means that both of those companies have huge pricing power.


strategic shift is paying off… accelerating momentum and a highly profitable product mix, management confidently raised their long-term growth forecasts

Summary: Bullish DOCN: AI services shift driving revenue acceleration, largest customers spending more, guidance raised.

$DOCN strategic shift is paying off, driving a solid 12% stock jump. They just landed a strong Q4 double beat.

The core takeaway is their successful evolution beyond basic cloud hosting into advanced AI services. Rather than just renting raw hardware, they are capturing high-value demand for running active AI applications.

This premium approach is working: their largest customers are drastically increasing their spending, and overall platform loyalty is rebounding strongly.

Thanks to this accelerating momentum and a highly profitable product mix, management confidently raised their long-term growth forecasts.


Summary: Bullish PLTR: Chain Reaction positions it as the grid OS layer, validating the thesis that software must optimize physical infra for AI scale.

@StockSavvyShay Energy is the new compute constraint. $PLTR securing the grid OS layer validates the thesis: software must optimize physical infrastructure to unlock true AI scale. Smart strategic pivot.

$PLTR launched Chain Reaction with $NVDA as an AI infra platform that unifies utilities, data centers & developers to forecast power demand as AI loads accelerate.

AI doesn’t scale without a coordination layer for power & Palantir is making it clear they plan to own that layer. https://t.co/FqVBMnxZiD


strong Q3 double beat … agentic cloud strategy is driving record new sales and strong profitability … Momentum is high, the company raised its FY25 guidance and accelerated its 2027 growth targets to 2026

Summary: Bullish DOCN: strong Q3 beat, raised guidance, and accelerated growth targets signal durable momentum.

$DOCN reported a strong Q3 double beat 🟢

Its agentic cloud strategy is driving record new sales and strong profitability, attracting larger AI customers. Momentum is high, the company raised its FY25 guidance and accelerated its 2027 growth targets to 2026.

$DOCN is up 10%📈 https://t.co/gLudmfuObq


Summary: Bullish PL as increasing big-account coverage will drive attention to the stock.

@SpaceInvestor_D $PL will be covered by more and more big accounts 👌🏼

Do you notice it too?

More and more "big accounts" are suddenly paying attention to space companies.

Always remember: you were early.


$BA is showing clear signs of recovery, delivering 160 jets in the fourth quarter which is its best performance since 2018... the company has returned to generating positive cash flow... Boeing is successfully rebuilding its delivery muscle and backlog

Summary: Bullish BA on recovery signs: record Q4 deliveries, return to positive cash flow, stabilizing 737 production, and growing backlog despite defense headwinds.

$BA with a massive Q4 beat. They EPS was unexpectedly positive (9.92 vs -0.41 est.), they also beat the revenue estimate. The stock is not really reacting to this massive beat as the massive profits are part of a one-time sale.

$BA is showing clear signs of recovery, delivering 160 jets in the fourth quarter which is its best performance since 2018. While reported profits appear massive, they were primarily inflated by a one-time $9.6 billion sale of a digital business unit rather than core operations.

Crucially, however, the company has returned to generating positive cash flow, driven by stabilizing 737 production rates and the strategic acquisition of supplier Spirit AeroSystems to ensure better safety and quality control.

While the Commercial division is ramping up, the Defense unit remains a drag on performance due to persistent cost overruns. Overall, Boeing is successfully rebuilding its delivery muscle and backlog, even as it navigates complex certification timelines for its future 777X jet.


Summary: Largest holding for 2 years, still holding; expects P/E to normalize via earnings growth not price drop, significant room to grow.

$PLTR is pushing through $200. It's been my largest holding for the past two years and it certainly hasn't disappointed.

Looking forward to seeing how the earnings turn out. https://t.co/K7l5vt57oN

---

Thanks! I think there's still significant room to grow.

While the P/E ratio is elevated in the short term, I expect it to normalize through earnings growth rather than a drop in the stock price.

I'm certainly not trimming the stock.


Summary: Long PLTR as largest position; expects climb to $200 starting today.

@cantonmeow It's my largest position by far as well. I expect them to start their climb to $200 today.

$PLTR is trying to reclaim the 20 period moving average on this 4 hour chart, but is at resistance after a gap-up.
It is my largest position by far, and I hope it does reclaim it back into support. Touching the lower Bollinger band is healthy, and if it reclaims this level when https://t.co/kvlMsKyTx3


GE Vernova is surging on the back of insatiable global electricity demand. They have locked in massive amounts of future work, pushing their backlog to a record $150 billion, importantly at much higher prices that guarantee better future profits.

Summary: Long GEV: record backlog at higher prices, gas turbine and grid demand accelerating from data centers, dividend doubled, buybacks expanded, Prolec acquisition expanding grid dominance.

$GEV with a massive double beat in Q4. They report a record EPS and Revenue. Stock is up 4% in pre-earnings.

GE Vernova is surging on the back of insatiable global electricity demand. While their Wind division remains a challenge, the Power and Electrification segments are booming. They have locked in massive amounts of future work, pushing their backlog to a record $150 billion, importantly at much higher prices that guarantee better future profits.

Demand for gas turbines and grid equipment is accelerating, driven by data centers and electrification trends. Management signals deep confidence by raising future financial targets, doubling the dividend, and expanding share buybacks.

With the Prolec GE acquisition closing soon, they are aggressively expanding their grip on the electrical grid, offsetting wind struggles with massive strength elsewhere.


Summary: Long NEE as a major beneficiary of the energy transition wave still in early stages.

@Real_Money_Blog The energy transition wave is juts getting started. Firms like $NEE will benefit hugely form
It.

$GOOGL just signed a 25-year deal with NextEra $NEE to restart Iowa’s Duane Arnold nuclear plant by 2029.

It’ll power Google’s AI and cloud data centers with carbon-free energy, marking a major comeback for U.S. nuclear as the backbone of AI infrastructure. $NLR


I really don't think that valuation is a problem. They got a solution that every company can use. Once integrated, a solution every company needs. So, I'm very relaxed with their position in my portfolio.

Summary: Still holding PLTR; dismisses valuation concerns, views it as an indispensable enterprise solution with continued upside.

Certainly not a tax thing but I bought them at $30 and I never touched the stock again. I just let it grow and it outperformed all the rest. That is why it is such a big part of my portfolio.

On the other hand, I really don’t think that valuation is a problem. They got a solution that every company can use. Once integrated, a solution every company needs.

So, I’m very relaxed with their position in my portfolio. Before the surge of $PL and $HOOD, they where around 20% of my portfolio.

@Kaizen_Investor With $PLTR sitting at such a large % of your portfolio I would love to hear your thoughts on it after the massive run up

Are you sitting on too much unrealized gains and it’s a tax call?

Or do you expect more growth into the future


Summary: Picks NVO as favourite from a list of high-ROIC, low-P/E stocks; implied bullish.

@TacticzH $NVO my clear favourite from the list

Companies with 25%+ ROIC trading below 16 times earnings:

SK Hynix:
ROIC: 27.6%
P/E: 14.5

$MRK - Merck & CO
ROIC: 26.6%
P/E: 14.4

$NVO - Novo Nordisk
ROIC: 26.6%
P/E 15.7

$UBER - Uber Holdings
ROIC: 27.2%
PE: 11

$PDD - PinDuoDuo
ROIC: 68.5%
PE: 12.5

*Data from fiscal


Summary: Holds IREN and ASML; both well positioned to benefit from data-center capacity tripling by 2030.

@TacticzH Got $IREN and $ASML in my portfolio, they should at least be well positioned to profit from the growing TAM.

Data Center Capacity could triple by as early as 2030 according to McKinsey.

Which company will profit the most?

- $NBIS
- $CRWV
- $CIFR
- $IREN
- $NVDA
- $TSM
- $ASML
- $VST
- $CEG https://t.co/7vMn1ijrCe


Summary: Author discloses a long position in Alphabet.

@InvestingVisual Great visuals! Long $GOOGL

How they make money: $GOOGL vs $NVDA https://t.co/ft61e5oG13


Summary: Highest-conviction long on Planet Labs; still much more room to run after 20% post-earnings pop.

$PL now up 20% after earnings tonight. It is my highest conviction stock since I bought them at $4 earlier this year. I believe there is still much more room to run.

If you want to know more about $PL 👇

$PL is quietly building the world's most valuable and irreplicable dataset - A time series archive of our planet itself.

Planet Labs is surfing on three waves that will define the stock market for years to come: Space economy, AI, and the environmental wave.

A deep dive https://t.co/qCTIms9gEf


$CIFR finally gets the appreciation it deserves 🤝

Summary: Bullish on CIFR; endorses the view that it is finally getting proper valuation recognition.


Summary: Bullish BE and ENPH on Q3 double beats; green energy transition wave accelerating.

With $BE and $ENPH both reporting Q3 double beats today, the underlying trend is undeniable.

The green energy transition wave isn't just continuing, it's accelerating.

Not all companies want to put their eggs in one basket. $IBE, $ENEL, $BE, $ENPH, and $VST are some examples.

The P/S peaked in 2020, but the total market cap is currently at its peak. Revenues have heavily declined since 2022, but the wave is showing a lot of promise again. https://t.co/VLHrYUvmFv


Summary: Bullish CIFR as a key AI infra supplier following $1.4B debt raise to expand power & data center footprint.

$CIFR is making an aggressive push to scale, raising $1.4B in secured debt to expand its power & data center footprint.

Capital is desperate for AI infra exposure, and recent raises prove the appetite is huge. This $1.4B move positions $CIFR as a key supplier in the buildout. https://t.co/y5yyzvKu35


Summary: Long US defense, domestic energy, and gold on prolonged Middle East conflict driving defense spending, energy premium, and safe-haven flows.

With the war expected to continue at least 4 more weeks, I expect American defense contractors and domestic energy producers to see renewed investor interest.

A long-term U.S. military posture in the Middle East will secure robust defense spending, while U.S. energy companies will profit from the premium placed on non-Middle Eastern oil.

Capital will also keep fleeing to traditional safe havens. Gold already saw a historic rally, surging past the $5,200-per-ounce mark in a massive double-digit monthly gain. Expect this to continue during war.

Make sure you are positioned.

Not financial advice.


Summary: Bought IREN below $60 today; live long position.

@moninvestor Bougt some Iren below $60 today.

What a crazy day. 😅
- $IREN and $CIFR recovered very well.
- $ONDS is entering deeply undervalued territory.
- $HIMS dropped below $40 for the first time in 5 months. Great opportunity.
- $ZETA and $SNAP finished flat relative to the rest.
> As expected. They’re my safe havens. https://t.co/Wa5PoY2iNe


Summary: Long PL with 300% upside to $67.3 PT on historical data moat, SaaS model, high switching costs, and defense/commercial contract pipeline vs SpaceX and Satellogic.

I got some questions regarding the competitors of $PL and how they protect margins. Here is my view, which is mainly economic.

1. SpaceX

I think SpaceX is a threat for every space company as they have everything. You are comparing an $8B company to a (potentially) $1.5T company, so of course Planet won't overtake SpaceX.

There are a few things why I think Planet will keep growing despite the pressure of SpaceX.

- Planet has a lot of historical data, which SpaceX has not. So if you want to do a historical analysis on a certain region, the data of Planet has to be used.

- They are only fighting over defensive contracts. Those defensive contracts are 60% of Planet's revenue (and the highest growing segment), but 40% of the revenues of Planet comes from the environmental sector, sustainability sector, private sector,... SpaceX has no interest in competing on that 40%.

- SpaceX's Earth observation network is a highly classified military project built exclusively for U.S. intelligence agencies. The government can't share any of the information with the outside world. They shared Planet's pictures as proof for "Operation Midnight Hammer" for example. They will always need the data of $PL.

- The most important part is that they actually operate best together on the defensive part. Planet scans the entire world 24/7, SpaceX does not do this. SpaceX does a specific task in a specific region. Planet also works on a SaaS business model, SpaceX operates on specific projects.

The government wants to scan the entire world to make sure they find all potential threats. They use Planet's images and AI to find potential threats. Once they identify a potential threat, they might use the more sophisticated technology of SpaceX to scan that region or do a specific task in that region.

- To make it easy, I compare this a bit with the music industry. You use Spotify (Planet) to scan the whole industry and for daily listening. You pay a (small) fee every month to listen to every artist in the world. Once you find a great artist, you want to see that artist live. Spotify can't give you that experience, so you buy a ticket to a concert (SpaceX). Instead of paying a monthly fee, you pay once (normally a bigger fee than the monthly fee) for that concert.

2. Satellogic

$SATL is actually trying to be the biggest disruptor of Planet Labs. Their satellites are working at a better resolution than the satellites of Planet. While Planet is trying to close the resolution gap with Satellogic, it looks like they can't fully close this gap.

Why I think Planet will stay superior

- Planet has a huge head start. They make a daily scan of the entire globe. They have around 180 SuperDoves in LEO. Satellogic only has 50 NewSats, which is roughly enough to scan the entire globe every 2 weeks.

To scan the entire Earth daily they will need around 150 more NewSats. $SATL missed their first target to have 200 NewSats in LEO, which was targeted in 2025. The new target is 2027, although sources indicate that 2029 will be more realistic.

- While $SATL will have to burn through cash for at least 4 more years, $PL recorded 3 positive cash flow quarters in a row already. They are using this cash to innovate their profit-making fleet. Satellogic will have to use every dollar to launch as many satellites as possible.

- Like SpaceX, Satellogic can only compete on defense contracts. Planet has acquired software and AI companies to translate their images into ready-to-use data feeds.

Instead of selling a farmer a picture of a field and making them figure it out, Planet directly sells them a data feed of soil water content or crop biomass. Satellogic is still primarily focused on selling the raw images.

- Planet doesn't just email a JPEG to a customer. Their data is directly piped into the internal software systems of the U.S. government, NATO, and massive agricultural corporations via APIs.

Once a major intelligence agency or a massive company like Bayer integrates Planet's data feeds into their daily, automated workflows, the switching cost is astronomically high. Even if Satellogic offers a slightly cheaper or sharper image, tearing out the foundational data plumbing of an entire intelligence agency to switch providers is a nightmare most customers won't do.

This is just my take. This is not financial advice, do your own research.

$PL remains my highest-conviction play in the space economy. Based on current fundamentals and their expanding contract pipeline, I see a clear path to a 300% upside from these levels.

Price target: $23.91 -> $67.3

Most investors look at Planet Labs and see satellites. They https://t.co/FslqUdx5wh


Summary: Bullish on ONDS over the next 5+ years despite not currently owning it.

@Ashton_1nvests Don’t own $ONDS but I’m very bullish

I’ve been seeing a lot more $ONDS on my feed lately.

Are you bullish or bearish on this stock over the next 5+ years? https://t.co/Yak9jrStv2


Summary: Bullish on IREN after massive revenue beat and $9.7B Microsoft AI Cloud contract; $3.4B ARR target by 2026.

$IREN just reported earnings, and it's super revenue beat.

They secured a $9.7 BILLION AI Cloud contract with Microsoft, validating their pivot. They are now targeting $3.4B in AI ARR by 2026 (140k GPUs) and accelerating data center construction to meet demand.

$IREN up 6% 📈 https://t.co/ayewlts8ex

$IREN will report earnings tonight.

Key metrics: AI Cloud (HPC) revenue ramp, progress on deploying their H100 GPU fleet, and updates on their data center power capacity (MW) expansion.

EPS est. $0.06
Rev est. $228M

What do you expect from the $IREN earnings tonight? https://t.co/kw5wksf9Un


Summary: Bullish LVMH; calls the recent dip a buying opportunity as luxury demand is durable and LVMH will remain dominant.

LVMH Moët Hennessy listed on Euronext Paris as MC.PA

Wall Street hit the panic button on $LVMH, but they're missing the golden rule: luxury is timeless.

As long as people desire the best, $LVMH will reign supreme. The recent dip isn't a red flag; it's a red carpet inviting you to own the king of luxury.

LVMH shares jumped after the luxury giant returned to sales growth for the 1ST time in three quarters.

Q3 revenue rose 1% organically to €18.28B, topping forecasts. Fashion and leather goods fell a modest 2% vs expectations of a deeper drop. Sales in China rose 2% after a 9% https://t.co/4bLAe400nu


$PL remains my highest-conviction play in the space economy. Based on current fundamentals and their expanding contract pipeline, I see a clear path to a 300% upside from these levels. Price target: $23.91 -> $67.3

Summary: Highest-conviction long PL with 300% upside to $67.3 PT; Pentagon SHIELD prime contractor win marks strategic shift to defense.

$PL just secured a seat at one of the biggest tables in the Pentagon. The company has been selected as a Prime Contractor for the Missile Defense Agency’s new SHIELD program.

Thie SHILED program is a pre-approved list that allows the U.S. government to buy high-tech defense tools at lightning speed over the next decade.

While Planet has worked with the government before, this marks a massive strategic shift for their business. They are moving beyond their original roots of tracking agricultural yields and climate change to become a core pillar of national security.

By using AI-enabled satellite data to detect missile threats and monitor global maritime activity in real-time, Planet is officially pivoting from a commercial data provider to a true defense prime.

For a company founded by NASA scientists, this is their most high-stakes mission yet. It proves their commercial satellites are now considered elite military-grade hardware, opening the door to a decade of massive government deals.

This isn't just about pictures anymore, it’s about Planet becoming the digital eyes and ears of a global defense shield.


$SBUX is officially seeing a turnaround... turnaround initiatives are executing ahead of schedule... predicting steady, sustainable growth for the rest of 2026

Summary: Bullish SBUX: turnaround executing ahead of schedule, U.S. traffic recovering, global sales rising, management guiding steady growth through 2026.

$SBUX with a mixed Q4 earnings report. They heavily missed EPS estimates but did beat the revenue estimates. Stock is up 6% after these earnings as turnaround initiatives are executing ahead of schedule.

$SBUX is officially seeing a turnaround. For the first time in two years, U.S. growth was driven by more customer visits rather than just higher prices, proving that the "Back to Starbucks" strategy is fixing store operations faster than expected.

Global sales rose 4%, with China rebounding strongly at 7% growth. However, profits dipped this quarter because the company is spending heavily on better staffing and coping with expensive coffee beans.

Despite the short-term cost, leadership is confident these investments are essential to keep customers happy, predicting steady, sustainable growth for the rest of 2026.


Summary: Bullish NOW: Armis acquisition expands moat via security-to-workflow integration and massive OT TAM expansion.

@StockSavvyShay This expands the moat significantly. Armis provides the visibility, $NOW provides the action. Merging security data directly into workflow automation is the holy grail. Massive TAM expansion into OT.

$NOW acquires Armis for ~$7B (its largest deal ever) adding device-level cyber security across IoT, medical & industrial endpoints.

Armis has scaled ARR from $200M to $300M in under year which gives ServiceNow a native cyber visibility layer that fits directly into its https://t.co/6fjnlWOv65


Summary: Long IREN (AI power), FLNC (grid battery storage), PL (satellite defense monitoring), AMPX (silicon anode energy density) as core infrastructure plays.

My core infrastructure stack:

1. The Power Bottleneck: $IREN
Chips are useless without juice. While hyperscalers fight for grid access, IREN is sitting on the power capacity they need. The pure-play on AI energy infrastructure.

2. The Grid Instability: $FLNC
AI data centers are destabilizing the grid. Renewables can't handle the load variance. Battery storage is the only patch, and Fluence has the backlog.

3. The Data Gap: $PL
You can't defend what you can't see. Defense spending is moving to real-time, daily satellite monitoring. Planet Labs owns the Google Earth Live monopoly.

4. The Weight Limit: $AMPX
Modern warfare (drones) and mobility (eVTOL) are hitting the limits of lithium-ion. Silicon anode is the only physics-based fix for energy density.

Don't buy the hype. Buy the plumbing.


Battery storage is the only patch, and Fluence has the backlog.


Planet Labs owns the Google Earth Live monopoly.


Silicon anode is the only physics-based fix for energy density.


Summary: Holds PLTR, HOOD, and CRWD as live long positions.

@Prof_heist I agree with your statement but certainly for $CRWD it is not that simple. In the cybersecurity it is not winner takes it all, simply because no one can do it all. A lot of different companies will play a major role in the cybersecurity wave. I own $PLTR, $HOOD, and $CRWD though.

$NVDA
$PLTR
$HOOD
$TSLA
$UBER
$CRWD
$NBIS

People remember the best — never the second best.


Summary: Long AMPX into 2026 on proprietary silicon nanowire anode tech offering 2x energy density and sub-6-min charging vs graphite competitors.

I've been looking into $AMPX lately, and I think this company could do really well again in 2026.

Lithium-ion batteries rely on graphite anodes, which have effectively reached their theoretical limit for energy storage. This creates a massive hurdle for industries that require lighter, longer-lasting, and faster-charging power sources.

The $AMPX solution is a 100% silicon nanowire anode. While silicon can theoretically store up to 10 times more lithium than graphite, it typically swells and cracks during charging. Amprius solves this with a proprietary nanowire structure grown directly onto the substrate. These nanowires have specific spacing that allows the silicon to expand freely without damaging the anode structure. This technology is particularly valuable for customers in sectors where performance and weight are critical, such as aerospace (drones, high-altitude pseudo-satellites), defense, and eventually, the electric vehicle market.

The performance leap over graphite cells is striking, particularly when you look at the raw density numbers. $AMPX cells achieve approximately double the energy density of conventional competitors, hitting peaks of 500 Wh/kg and 1,300 Wh/L compared to the standard ~285 Wh/kg and ~715 Wh/L found in graphite cells. In practical terms, this means for a fixed energy capacity, their batteries are effectively half the weight of current market leaders.

Beyond just holding more power, the unique nanowire architecture clears a direct path for electron flow, enabling extreme fast charging. While typical cells often require 30 minutes or more to recharge, Amprius technology supports charging speeds of under 6 minutes. This performance is maintained across a much wider operating window than we are used to, functioning effectively from -30°C to 60°C, making them suitable for extreme environments where standard batteries would fail.

Furthermore, despite using pure silicon, the technology offers a robust cycle life ranging from 200 to 1,200 cycles depending on the specific cell design. By overcoming the fundamental limitations of graphite, Amprius is positioned to be a key player in the next generation of high-performance energy storage.


Summary: Bloomberg's 8x energy storage capacity forecast to 2TW by 2035 creates bullish backdrop for FLNC, EOSE, TSLA, and STEM.

Bloomberg projects global energy storage capacity to skyrocket eight-fold, reaching 2TW by 2035.

This aggressive ramp-up signals a massive secular shift, creating a bullish backdrop for infrastructure leaders $FLNC and $EOSE, alongside key peers like $TSLA and $STEM. https://t.co/C9u6AMT8LD


Summary: Buying IREN on the dip caused by the fake Oracle/space story, expects significant gains.

@moninvestor We need this kind of news Mon, it seperates the investors who know what they own to the candle bar investors. This news is the reason I can buy more $IREN in this dip and make a lot of money. If investors are perfect, we wouldn’t be able to beat any index.

People who sold $IREN, $CIFR, or $NBIS because of the “data center in space” narrative or the fake Oracle story should stick to index funds, contribute monthly, delete the app from their phone, and leave it alone for 30 years.


Summary: HIMS back above $40 next week.

@Cbmethod $HIMS back above $40 next week


Summary: Bullish NBIS; expects it to outperform NVDA/AMZN/MSFT/META.

@BullMarketBoss @babyfolio Thanks Boss, $NBIS will outrun those imo

@Kaizen_Investor @babyfolio Great thread 🧵

$NBIS is an AI infrastructure Rule Breaker riding the same wave as $NVDA $AMZN $MSFT $META


Summary: Names IREN, HIMS, and FLNC as top picks for 2026.

@Dividend_Learn My 3 picks for 2026 are $IREN, $HIMS and $FLNC

@Kaizen_Investor Would you add anything to the list?


Summary: Holds GOOGL as fifth largest position; ongoing long.

@Iron_Mind001 Yeah, $GOOGL is my fifth largest position haha

@Kaizen_Investor I'm honestly more bullish on $GOOGL than anything. They seem to have their hands in everything, definitely a major Roth holding for me.


the steady subscriber growth proves my long-term bull thesis is firmly intact. For patient investors, however, those could be excellent buying opportunities.

Summary: Long HIMS long-term on intact bull thesis; near-term pressure creates buying opportunities; NVO tie-up noted.

I think the $HIMS earnings buy the management some time, but they likely aren't enough to kill all the short-term noise just yet.

The Q4 Adjusted EBITDA guidance implies a sequential drop from Q3, signaling heavy reinvestment. This, combined with gross margin compression (74% vs 79% YoY) and flat year-over-year Free Cash Flow, shows there are real execution questions.

Revenue growth remains blistering at 49% YoY ($599M). More importantly, the platform is working: $HIMS grew subscribers by 21% while simultaneously increasing the Monthly Revenue per Subscriber by 19%. This proves they are successfully cross-selling and moving users to higher-value services.

On top of that, they confirmed "active discussions" with $NVO to offer Wegovy.

Ultimately, the steady subscriber growth proves my long-term bull thesis is firmly intact. This may take longer to play out than many expected, which will likely keep the stock under pressure short-term. For patient investors, however, those could be excellent buying opportunities.

$HIMS posts strong Q3.

Revenue grew 49% & subscribers hit 2.5M (up 21% Y/Y). Profitability continues with $16M net income & 53% Adj. EBITDA growth. $HIMS is in active talks with $NVO to offer Wegovy. 2025 guidance narrowed. https://t.co/lq1Se3AHfw


they confirmed 'active discussions' with $NVO to offer Wegovy


Summary: Bullish PL as a key data provider for the AI/space economy with continued upside.

$PL continues its parabolic run.

$Pl delivers the data that the AI-economy needs. Without data, there is no AI. Planet Labs will keep playing a massive part in the space-economy wave. https://t.co/1pk105JDtN


Summary: NVDA's $2B investment in NBIS for hyperscale AI cloud co-development is very bullish for NBIS shareholders.

$NVDA invests $2B in $NBIS to co-develop full-stack, hyperscale AI clouds.

Target: Deploy >5 GW of capacity by 2030.

Focus: AI factory design, inference optimization, & scaling hardware for Agentic AI.

Very bullish for $NBIS shareholders https://t.co/zsTVzuDvUX


Summary: Endorses early-cycle compounding thesis for hyperscalers MSFT/GOOGL/AMZN on sustained enterprise AI pull-through; fundamentals leading price.

The key takeaway is not AI hype, but earnings quality. When Hyperscalers see sustained enterprise pull-through, this looks like an early-cycle compounding phase instead of a late-cycle blow-off. Fundamentals still lead price.

We believe tech stocks will have a very strong 4Q earnings season led by Big Tech as the cloud stalwarts Microsoft, Alphabet, and Amazon had very robust AI enterprise demand in the quarter based on our field checks. This is a mid-1996 Moment ...and NOT a 1999 Moment for tech 🔥🐂


Disney's latest results show a company successfully pivoting its business model... streaming profits are surging... Theme parks remain a powerhouse... With a massive $7 billion stock buyback planned, $DIS is betting big on its own long-term recovery

Summary: Bullish DIS post-earnings: streaming profits surging, parks strong, $7B buyback signals long-term recovery conviction.

$DIS with a strong double beat in Q4. The stock is +4% after these strong earnings 🟢

Disney’s latest results show a company successfully pivoting its business model, though not without growing pains. The big win is in streaming (SVOD), where profits are surging as more people subscribe and stay engaged. At the box office, hits like Zootopia 2 and Avatar prove Disney has regained its creative spark, driving fans back to theaters.

Theme parks remain a powerhouse, despite global economic shifts, families are spending more per visit on cruises and attractions. However, it’s not all magic. The Sports (ESPN) division is struggling with the high cost of broadcasting rights, and overall profits were dampened by heavy investments in new technology.

With a massive $7 billion stock buyback planned, $DIS is betting big on its own long-term recovery.